Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
Follow-Up Questions
¿Cuál es el ratio P/E de Poniard Pharmaceuticals Inc (PARD)?
El ratio P/E de Poniard Pharmaceuticals Inc es 0
¿Qué tal es el rendimiento del precio de la acción PARD?
El precio actual de PARD es de $0.0001, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Poniard Pharmaceuticals Inc?
Poniard Pharmaceuticals Inc pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Poniard Pharmaceuticals Inc?
La capitalización bursátil actual de Poniard Pharmaceuticals Inc es $150
